FAST DISSOLVING TABLETS: A PROMISING APPROACH FOR DRUG DELIVERY

  • Vaishali Chauhan Global Institute of Pharmaceutical Education and Research, Kashipur, Uttarakhand, India
  • Kapil Kumar Global Institute of Pharmaceutical Education and Research, Kashipur, Uttarakhand, India
  • Deepak Teotia Global Institute of Pharmaceutical Education and Research, Kashipur, Uttarakhand, India

Abstract

Aim of novel drug delivery system is to enhance safety and efficacy of drug molecules by formulating a convenient dosage form for administration and to achieve better patient compliance. One such approach led to development of fast dissolving tablets. Now-a-days fast disintegrating tablets (FDTs) gaining significance with wide variety of drugs serving many purposes. These are novel types of tablets that disintegrate/dissolve/ disperse in saliva within few seconds (less than 60 seconds) without chewing and additional water. The basic approach used in development of FDTs is the use of superdisintegrants and the elimination of bitterness. FDTs reduces the disadvantages of conventional dosage form especially dysphasia (difficulty in swallowing) in pediatric and geriatric patients. These oral dosage forms have many benefits such as self medication, increased compliance, ease of manufacturing and noninvasive. This review presents description of fast dissolving tablets including need for development, challenges in formulation, suitability of drug candidates, composition, various technologies involved, advantages, disadvantages, and evaluation parameters.


                                    111.JPG


google_s_2.JPG     PubMed12.jpg


Peer Review History:


Received 19 August 2017;   Revised 28 August; Accepted 5 September, Available online 15 September 2017


Academic Editor: 


Dr. A.A. Mgbahurikeorcid22.jpg, University of Port Harcourt, Nigeria, amaka_mgbahurike@yahoo.com


UJPR follows the most transparent and toughest ‘Advanced OPEN peer review’ system. The identity of the authors and, reviewers will be known to each other. This transparent process will help to eradicate any possible malicious/purposeful interference by any person (publishing staff, reviewer, editor, author, etc) during peer review. As a result of this unique system, all reviewers will get their due recognition and respect, once their names are published in the papers. We expect that, by publishing peer review reports with published papers, will be helpful to many authors for drafting their article according to the specifications. Auhors will remove any error of their article and they will improve their article(s) according to the previous reports displayed with published article(s). The main purpose of it is ‘to improve the quality of a candidate manuscript’. Our reviewers check the ‘strength and weakness of a manuscript honestly’. There will increase in the perfection, and transparency.


Received file:blue_23983.gif        Reviewer's Comments:download_logo_r_29189.gif


Average Peer review marks at initial stage: 4.0/10


Average Peer review marks at publication stage: 7.0/10


Reviewer(s) detail:


Dr. Ogbonna B. Onyebuchiorcid22.jpg, Nnamdi Azikiwe University, Awka,  Nigeria, summitpharm@yahoo.com


Dr. Gülay B Anadoluorcid22.jpg, Anadolu University, Eskisehir, Turkey, gbuyukko@anadolu.edu.tr


 Similar Articles:


FORMULATION AND EVALUATION OF FAST DISSOLVING TABLETS OF ANTIEPILEPTIC DRUG


IN VITRO-IN VIVO BIO-EQUIVALENCE CORRELATION STUDY OF ATENOLOL, AND ITS BRANDS OF IMMEDIATE RELEASE TABLET UNDER BIO-WAIVER CONDITIONS


This article has been cited by:


Recent developments in orally disintegrating mini tablets Sachin Sarashetti, Vikas Jain, Gowda D V, Pooja Mallya, Satish Babu. International journal of research in pharmaceutical sciences 2020, 11(3), 3606-3612. Pubmed

Keywords: Fast dissolving tablet, superdisintegrants, disintegration

Downloads

Download data is not yet available.
Comments

Statistics
468 Views | 543 Downloads
How to Cite
Chauhan, V., K. Kumar, and D. Teotia. “FAST DISSOLVING TABLETS: A PROMISING APPROACH FOR DRUG DELIVERY”. Universal Journal of Pharmaceutical Research, Vol. 2, no. 4, July 2017, doi:https://doi.org/10.22270/ujpr.v2i4.RW4.
Section
Review Articles